High-Efficacy Therapy Cuts Disability Progression in Pediatric MS

FRIDAY, April 12, 2024-- Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue of The Lancet Child...